We have located links that may give you full text access.
Graphene-encapsulated Co9S8 nanoparticles decorated N, S co-doped carbon nanotubes: An efficient bifunctional oxygen electrocatalyst for rechargeable zinc-air battery.
ChemSusChem 2019 March 21
An inexpensive and efficient bifunctional electrocatalyst for the oxygen reduction reaction (ORR) and the oxygen evolution reaction (OER), is central to the rechargeable zinc-air battery. Herein, a novel nanohybrid, N and S co-doped carbon nanotubes decorated with porous graphene layers encapsulated Co9S8 nanoparticles, was fabricated by one-step heat treatment process. The N, S doped species are major activity sites for the ORR, while Co9S8 nanoparticles are mainly responsible for the OER. Compared with commercial 20wt% Pt/C and Ir/C electrocatalysts, this nanohybrid exhibits comparable ORR half-wave potential (0.831 V vs. RHE) and OER potential (1.591 V at 10 mA·cm-2), better long-term stability in an alkaline medium, as well as a narrower potential gap (0.76 V) between ORR and OER. Furthermore, as air electrode of the rechargeable zinc-air battery, it delivers low charge-discharge voltage gap (0.65 V at 5 mA·cm-2), high open circuit potential (1.539 V), good specific capacity of 805 mA h gZn-1 (at 5 mA·cm-2) and excellent cycling stability (48 h), superior to the commercial Pt/C+Ir/C catalyst, demonstrating promising applications for renewable energy conversion devices.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app